Response by Docherty et al to Letter Regarding Article, “Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial”

Kieran F. Docherty; Alasdair D. Henderson; Pardeep S. Jhund; Scott D. Solomon; John J.V. McMurray

doi:10.1161/circulationaha.125.075278

Response by Docherty et al to Letter Regarding Article, “Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial”

K Kieran F. Docherty (BHF Cardiovascular Research Centre, University of Glasgow, Scotland, UK (K.F.D., A.D.H., P.S.J., J.J.V.M).) A Alasdair D. Henderson (BHF Cardiovascular Research Centre, University of Glasgow, Scotland, UK (K.F.D., A.D.H., P.S.J., J.J.V.M).) P Pardeep S. Jhund (BHF Cardiovascular Research Centre, University of Glasgow, Scotland, UK (K.F.D., A.D.H., P.S.J., J.J.V.M).) S Scott D. Solomon (Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston) J John J.V. McMurray (British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom (J.J.V.M.).)

View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal Circulation

Volume / Issue Vol. 152, Issue 7

Published August 19, 2025

DOI 10.1161/circulationaha.125.075278

ISSN 0009-7322

Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (5)

K

Kieran F. Docherty

BHF Cardiovascular Research Centre, University of Glasgow, Scotland, UK (K.F.D., A.D.H., P.S.J., J.J.V.M).

A

Alasdair D. Henderson

BHF Cardiovascular Research Centre, University of Glasgow, Scotland, UK (K.F.D., A.D.H., P.S.J., J.J.V.M).

P

Pardeep S. Jhund

BHF Cardiovascular Research Centre, University of Glasgow, Scotland, UK (K.F.D., A.D.H., P.S.J., J.J.V.M).

S

Scott D. Solomon

Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston

J

John J.V. McMurray

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom (J.J.V.M.).

Response by Docherty et al to Letter Regarding Article, “Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial”

Article Details

Journal Info

Authors (5)

Related Articles from this Journal

Occupational Radiation Safety in Electrophysiology During Pregnancy: Evaluating Uterine Radiation Doses During Catheter Ablations and Device Implantations

Response by Rogers et al to Letter Regarding, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”

Clinical Cardiology at the Crossroads: Perspectives on the Next Era at <i>Circulation</i>

ABHD11-Mediated mtDNA Transcription Restored Mitochondrial Function to Attenuate Cardiomyocyte Ferroptosis After Myocardial Infarction

Letter by Li et al Regarding Article, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”